AnimalTFDB 4.0: a comprehensive animal transcription factor database updated with variation and expression annotations

WK Shen, SY Chen, ZQ Gan, YZ Zhang… - Nucleic acids …, 2023 - academic.oup.com
Transcription factors (TFs) are proteins that interact with specific DNA sequences to regulate
gene expression and play crucial roles in all kinds of biological processes. To keep up with …

Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis

A Yu, L Zhao, Q Kang, J Li, K Chen, H Fu - Translational Research, 2020 - Elsevier
Cholangiocarcinoma, which is the most common invasive malignant tumor of the biliary tract,
has poor prognosis. There is evidence suggesting that hypoxia-inducible factor 1α (HIF1α) …

PU. 1 negatively regulates tumorigenesis in non-small-cell lung cancer

X Liu, M Xu, W Jia, Y Duan, J Ma, W Tai - Medical Oncology, 2023 - Springer
PU. 1 is a key transcription factor that modulates hematopoietic cell differentiation and is
involved in various physiological and pathological processes. PU. 1 has been described to …

Detection and independent validation of model-based quantitative transcriptional regulation relationships altered in lung cancers

M Duan, H Song, C Wang, J Zheng, H Xie… - … in Bioengineering and …, 2020 - frontiersin.org
Differential expressions of genes are widely evaluated for the diagnosis and prognosis
correlations with diseases. But limited studies investigate how transcriptional regulations are …

Identifying polymorphic cis-regulatory variants as risk markers for lung carcinogenesis and chemotherapy responses in tobacco smokers from eastern India

D Sengupta, P Mukhopadhyay, S Banerjee… - Scientific Reports, 2023 - nature.com
Aberrant expression of xenobiotic metabolism and DNA repair genes is critical to lung
cancer pathogenesis. This study aims to identify the cis-regulatory variants of the genes …

Lung Cancer through Transcription Factors

KA Papavassiliou, N Anagnostopoulos… - International Journal of …, 2023 - mdpi.com
The body of knowledge on the molecular mechanisms that drive lung cancer, including non-
small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), is continuously growing …

Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells

L Fu, L Guo, Y Zheng, Z Zhu, M Zhang… - Oncology …, 2018 - spandidos-publications.com
Sorafenib is a multikinase inhibitor that is frequently used to treat various types of malignant
tumors. However, it has been demonstrated that Sorafenib only has a moderate antitumor …

Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer

HG Kang, JE Park, SY Lee, JE Choi, SK Do, MJ Hong… - Oncology, 2021 - karger.com
Background: Activating transcription factor 3 (ATF3) plays a significant role in cancer
development and progression. We investigated the association between variants in …